Drug interactions
Crizanlizumab + Exagamglogene autotemcel
Severity: Moderate
Crizanlizumab and Exagamglogene autotemcel: moderate interaction.
Last updated
For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.
Summary
Crizanlizumab given close to stem cell mobilization and myeloablative conditioning may compromise the collection of cells and the conditioning process. This could affect manufacture and engraftment of the gene-edited product.
What this interaction means in plain words
Crizanlizumab and Exagamglogene autotemcel can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken.
Crizanlizumab belongs to Miscellaneous; Exagamglogene autotemcel belongs to Miscellaneous.
Why it happens
The mechanism is not well established; crizanlizumab blocks P-selectin, which may affect stem cell mobilization and cell trafficking.
What to do
Stop crizanlizumab at least 8 weeks before mobilization and conditioning, as stated in labeling.
What to ask your pharmacist
- Should I take them at different times of day?
- Does the dose of either medicine need to change?
- Is there anything I should avoid, such as alcohol or certain foods, while on both?
Pro+ members
Unlock the full page
Create an account and start a Pro+ trial to unlock the full management advice for Crizanlizumab and Exagamglogene autotemcel, the additional notes, the evidence detail and the whole-prescription interaction checker.
- Full clinical management advice
- Additional notes
- Evidence detail
- Interaction checker for a whole prescription
Try Pro+ free for 14 days on the web. No card needed.
Other interactions of Exagamglogene autotemcel
Frequently asked questions
Can I take Crizanlizumab with Exagamglogene autotemcel?
MediHelp rates the interaction as moderate. Crizanlizumab and Exagamglogene autotemcel can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken. Crizanlizumab given close to stem cell mobilization and myeloablative conditioning may compromise the collection of cells and the conditioning process. This could affect manufacture and engraftment of the gene-edited product.
How serious is the interaction between Crizanlizumab and Exagamglogene autotemcel?
MediHelp rates it moderate, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: Stop crizanlizumab at least 8 weeks before mobilization and conditioning, as stated in labeling.
What other medicines interact with Exagamglogene autotemcel?
MediHelp also lists interactions of Exagamglogene autotemcel with, for example, Deferasirox, Deferiprone, Deferoxamine. The full list is on the Exagamglogene autotemcel page.
Full monographs, dosing and an interaction checker in the MediHelp app
Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.
